NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/25/2025
Back to search
Official data from USPTO
GEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
09/26/2025
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/27/2008
Registration date
11/02/2010
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/30/2021
Last transaction
09/26/2025
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Berlin, DE
Examiner
MORRIS,KRISTINA KLOIBER
Law office
M70
Holders and representatives
Holders
Glycotope GmbH
Glycotope GmbH
Representatives
Leigh Ann Lindquist SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industryscience and photographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elementsfragmentsfractions and lysates thereofexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatmentbacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cellsexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatment; biological preparations for laboratoriesexcept for medical or veterinary purposesfor use in bacterial and cell engineeringcultivationharvestingprotein production; chemical preparations for analysis in laboratoriespreparations for proteinpeptideengineered proteins and peptidesglycoproteinsglycosylationantibody or antigen analysispreparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein productionbacterial and cell engineeringcultivation and harvestingprobes for detecting and analyzing molecules in protein or nucleotide arraysexcept for medical or veterinary purposes; diagnostic preparationsexcept for medical or veterinary purposes; enzymesproteins and respective preparations for industrial purposesengineered proteinsglycosylated proteinsantibodiesenzymes for use in glycosylationenzyme substratesproteins used in the manufacture of cosmeticsbeveragesfood products and food supplements; ferments for chemical purposesyeastbacteriummoldenzymethat causes fermentation; in-vitro diagnosticsother than for medical purposes; carbohydrates for use in the manufacture of food and nutraceuticals; cultures of microorganisms and cells and elementsfragmentsfractions and lysates thereofother than for medical or veterinary purposescultures of microorganisms and cells other than for medical and veterinary usemicroorganism or cell cultures for use in protein productionfood manufacturingscientific researchwaste water treatmentcultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; expression systems for proteins and peptides comprising cellsparticularly human cells and microorganisms suitable for expressing engineered or glycosylated proteins or peptidescapable of providing optimized glycosylation; milk ferments for medical research purposes
Class 5
Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; materials for dental filling and impression materials for dental purposes; disinfectants for sanitary purposes; preparations for destroying vermin; fungicidesherbicides; adjuvants for medical purposes; Medicines for human and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzymeproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicineas nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; microorganismscells and preparations containing elementsfragmentsfractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological therapeuticstherapeutics containing cellsmicroorganismsproteinsglycoproteinspeptidesglycopeptides or modified or conjugated versions thereof ; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposesenzymesproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof as nutritional additives; sugar and carbohydrates for medical purposestherapeutically and prophylactically active sugar and carbohydratesdietetic sugar and carbohydratessugar and carbohydrate replacements
Class 42
Scientific and technological services and research and designer services relating theretoscientific researchscientific analysistechnology consultation and researchproduct development and optimization in the field of biotechnologyprotein productionglycosylationoptimization of proteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; industrial analysis and research services in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; design and development of computer hardware and software; biological research; services of a chemical or biological laboratory; technical surveysconducting biotechnology surveyspharmacology surveys; conducting scientific surveys in the field of biotechnologybacterial and cell engineeringprotein productionglycosylation; research and development in the field of bacteriologycytologyantibody technologychemistryimmunologycosmetics of expression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesparticularly for proteins and peptides; quality control; research and development of new products and technologies in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting for others; technology and scientific consultancy in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; research and development in the field of glycomicsexpression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesdevelopment and improvement of cellscell lines and microorganismsantibody-engineeringoptimised biological therapeuticsnutraceuticalsfood and nutritional supplements; researchquality controltechnology consultancy and product development in the field of proteinsantibodiesmicroorganisms and cells; research and development in the field of microorganisms and cells
Publications
History of USPTO decisions and trademark events.
58 publications found
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/02/2022
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/23/2022
INPC
INVALIDATION PROCESSED
08/23/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/30/2022
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/30/2021
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
10/30/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/28/2021
PR71
POST REGISTRATION ACTION MAILED - SEC.71
05/06/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/20/2021
ES71
TEAS SECTION 71 RECEIVED
11/02/2020
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
07/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/02/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/13/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/04/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/01/2018
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
03/30/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/30/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/20/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
06/23/2017
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
06/23/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/20/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
04/27/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/14/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/18/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/11/2011
FIMP
FINAL DISPOSITION PROCESSED
02/11/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/02/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2010
PUBO
PUBLISHED FOR OPPOSITION
08/17/2010
CNEA
EXAMINERS AMENDMENT MAILED
07/16/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/15/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/15/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
07/15/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/15/2010
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/15/2010
CNEA
EXAMINERS AMENDMENT MAILED
07/15/2010
CNFR
FINAL REFUSAL MAILED
01/20/2010
CNFR
FINAL REFUSAL WRITTEN
01/19/2010
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/01/2010
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
12/31/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2009
ALIE
ASSIGNED TO LIE
12/28/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2009
RFNT
REFUSAL PROCESSED BY IB
07/10/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2009
RFRR
REFUSAL PROCESSED BY MPU
06/15/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/13/2009
CNRT
NON-FINAL ACTION WRITTEN
06/12/2009
MAFR
APPLICATION FILING RECEIPT MAILED
06/09/2009
DOCK
ASSIGNED TO EXAMINER
06/05/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/04/2009
Continuous trademark protection
Get notified about every new filing that threatens GEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.